Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mapping of Urinary Complement Peptides in Kidney Diseases. | Proteomes | 2021 | 34941814 | PubTator, text mining | PubMed |
| Intersection of Epigenetic and Immune Alterations: Implications for Fetal Alcohol Spectrum Disorder and Mental Health. | Front Neurosci | 2021 | 34924946 | PubTator, text mining | PubMed |
| Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy. | Exp Hematol Oncol | 2021 | 34924021 | PubTator, text mining | PubMed |
| Malignancy and immune disorders in patients with hereditary angioedema. | Allergy Asthma Clin Immunol | 2021 | 34924008 | PubTator, text mining | PubMed |
| Proteomic analysis of extracellular vesicles enriched serum associated with future ischemic stroke. | Sci Rep | 2021 | 34912031 | PubTator, text mining | PubMed |
| Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. | Nat Commun | 2021 | 34911940 | PubTator, text mining | PubMed |
| Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein. | Front Immunol | 2021 | 34899688 | PubTator, text mining | PubMed |
| Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs. | Front Immunol | 2021 | 34899680 | PubTator, text mining | PubMed |
| Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Front Microbiol | 2021 | 34899651 | PubTator, text mining | PubMed |
| Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48. | Sci Adv | 2021 | 34878835 | PubTator, text mining | PubMed |
| Multi-omics approach to COVID-19: a domain-based literature review. | J Transl Med | 2021 | 34876157 | PubTator, text mining | PubMed |
| COVID-19, Pre-Eclampsia, and Complement System. | Front Immunol | 2021 | 34868042 | PubTator, text mining | PubMed |
| Identification and characterization of an atypical Gαs-biased β2AR agonist that fails to evoke airway smooth muscle cell tachyphylaxis. | Proc Natl Acad Sci U S A | 2021 | 34857633 | PubTator, text mining | PubMed |
| Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC. | J Hepatocell Carcinoma | 2021 | 34849372 | PubTator, text mining | PubMed |
| Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics. | Adv Immunol | 2021 | 34844708 | PubTator, text mining | PubMed |
| Physicochemical and Biological Characterization of rhC1INH Expressed in CHO Cells. | Pharmaceuticals (Basel) | 2021 | 34832963 | PubTator, text mining | PubMed |
| Changes in Expression of Complement Components in the Ovine Spleen during Early Pregnancy. | Animals (Basel) | 2021 | 34827915 | PubTator, text mining | PubMed |
| Systemic Effects of Hemorrhagic Snake Venom Metalloproteinases: Untargeted Peptidomics to Explore the Pathodegradome of Plasma Proteins. | Toxins (Basel) | 2021 | 34822548 | PubTator, text mining | PubMed |
| SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation. | Front Immunol | 2021 | 34804055 | PubTator, text mining | PubMed |
| The Alterations in Methylene Blue/Light-Treated Frozen Plasma Proteins Revealed by Proteomics. | Transfus Med Hemother | 2021 | 34803573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=38